These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 35131485)

  • 1. Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease who Underwent Haploidentical Hematopoietic Stem Cell Transplantation.
    Shaikh A; Olkhanud PB; Gangaplara A; Kone A; Patel S; Gucek M; Fitzhugh CD
    Transplant Cell Ther; 2022 May; 28(5):249.e1-249.e13. PubMed ID: 35131485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease.
    Bhat DK; Olkhanud PB; Gangaplara A; Seifuddin F; Pirooznia M; Biancotto A; Fantoni G; Pittman C; Francis B; Dagur PK; Saxena A; McCoy JP; Pfeiffer RM; Fitzhugh CD
    Front Immunol; 2021; 12():757279. PubMed ID: 34917079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
    Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
    JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
    Gluckman E; Cappelli B; Scigliuolo GM; De la Fuente J; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):181-188. PubMed ID: 32201153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease.
    Saraf SL; Oh AL; Patel PR; Sweiss K; Koshy M; Campbell-Lee S; Gowhari M; Jain S; Peace D; Quigley JG; Khan I; Molokie RE; Mahmud N; Gordeuk VR; Rondelli D
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1759-1765. PubMed ID: 29656137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients.
    de Azevedo JTC; Costa TCM; Lima KC; Maciel TT; Palma PVB; Darrigo-Júnior LG; Setanni Grecco CE; Stracieri ABPL; Elias JB; Pieroni F; Guerino-Cunha RL; Pinto ACS; De Santis GC; Covas DT; Hermine O; Simões BP; Oliveira MC; Malmegrim KCR
    Front Immunol; 2021; 12():774442. PubMed ID: 34956203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of donor cell engraftment after hematopoietic stem cell transplantation for sickle cell disease: A review of current and future methods.
    Lewis J; Greenway SC; Khan F; Singh G; Bhatia M; Guilcher GMT
    Am J Hematol; 2022 Oct; 97(10):1359-1371. PubMed ID: 35583381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
    Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A retrospective comparative study of haplotype hematopoietic stem cell transplantation and human leukocyte antigen-matched sibling donor hematopoietic stem cell transplantation in the treatment of acute B-lymphocyte leukemia].
    Wang ZD; Sun YQ; Yan CH; Wang FR; Mo XD; Lyu M; Zhao XS; Han W; Chen H; Chen YY; Wang Y; Xu LP; Wang YZ; Liu YR; Cheng YF; Zhang XH; Liu KY; Huang XJ; Chang YJ
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):221-228. PubMed ID: 35405780
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
    Tsai SB; Liu H; Shore T; Fan Y; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Martinez G; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1065-1072. PubMed ID: 26912055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Risk Factors Associated With Graft Failure of Haploidentical Hematopoietic Stem Cell Transplantation in Children With Sickle Cell Disease.
    Yu J; Black V; Lamba J; Horn B
    J Pediatr Hematol Oncol; 2021 May; 43(4):e583-e586. PubMed ID: 32604335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
    Zhang RL; Zheng XH; Zhou LK; Zhang Y; Chen SL; Yang DL; Jiang EL; Wei JL; Huang Y; Ma QL; Zhai WH; Feng SZ; Han MZ; He Y
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):190-195. PubMed ID: 29562462
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease.
    Leonard A; Furstenau D; Abraham A; Darbari DS; Nickel RS; Limerick E; Fitzhugh C; Hsieh M; Tisdale JF
    Blood Adv; 2023 Jan; 7(2):227-234. PubMed ID: 36240296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia].
    Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
    Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
    Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease.
    Pawlowska AB; Cheng JC; Karras NA; Sun W; Wang LD; Bell AD; Gutierrez L; Rosenthal J
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):185-189. PubMed ID: 28939451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pre-existing HLA and red blood cell antibodies on transfusion support and engraftment in sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation from HLA-matched sibling donors: A prospective, single-center, observational study.
    Nickel RS; Flegel WA; Adams SD; Hendrickson JE; Liang H; Tisdale JF; Hsieh MM
    EClinicalMedicine; 2020 Jul; 24():100432. PubMed ID: 32637902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
    Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
    Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.